查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
持續血糖監測市場 - 成長、未來展望、競爭分析，2025 年至 2033 年
市場調查報告書
商品編碼
1665882

持續血糖監測市場 - 成長、未來展望、競爭分析，2025 年至 2033 年

Continuous Glucose Monitoring Market - Growth, Future Prospects and Competitive Analysis, 2025 - 2033
出版日期: | 出版商: Acute Market Reports | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

持續血糖監測 (CGM) 系統是一種先進的醫療設備，可全天候即時追蹤血糖濃度。該系統可以讓糖尿病患者透過連接在他們身上的感測器即時查看自己的血糖濃度，或遠端查看幾天內的血糖水平。 CGM 系統提供的資料可用於識別血糖濃度的趨勢和模式，幫助調整飲食、運動和胰島素需求。這項技術對於糖尿病管理至關重要，因為它可以提供對血糖動態的全面了解，而不像傳統的血糖儀每次只能提供單一的血糖讀數。由於全球糖尿病盛行率不斷上升以及對即時血糖監測解決方案的需求不斷增加，持續血糖監測市場規模預計將以 9.6% 的年複合成長率（CAGR）成長。

持續血糖監測 (CGM) 市場的關鍵促進因素是全球糖尿病盛行率的上升。糖尿病已成為全球流行病，預計2021年全球成年人糖尿病患者人數將達5.37億，2030年將增加6.43億。這種激增主要是由於肥胖、不良飲食習慣和久坐的生活方式的增加，尤其是在都市區。不斷成長的糖尿病患者需要有效的管理工具來監測和控制血糖值，從而推動了對 CGM 系統的需求。這些設備可以即時洞察血糖趨勢，使患者能夠更有效地管理病情，並及時進行干預，從而降低低血糖和高血糖等糖尿病相關併發症的風險。

CGM 設備與更廣泛的數位健康平台的整合將大大增強 CGM 市場的成長機會。隨著數位健康技術的進步，開發能夠整合來自多個來源（包括 CGM 系統）的資料的平台以全面了解患者的健康狀況的趨勢日益成長。這種整合使得更個人化和精準的糖尿病管理策略成為可能，並得到了人工智慧和機器學習演算法的支持，可以根據飲食、運動和其他健康資料預測血糖波動。此外，與醫療保健提供者無縫共用這些資料的能力增強了遠端監控能力，並有助於從遠端位置進行有效的糖尿病管理，這在全球繼續向遠端醫療和遠距健康管理轉變的背景下尤為重要。

本報告研究了全球連續血糖監測市場，並提供了市場概況、設備/品牌、地區趨勢以及參與市場的公司概況。

目錄

第 1 章 簡介

第 2 章執行摘要

3. 持續血糖監測市場：競爭分析

  • 主要供應商的市場定位
  • 供應商所採用的策略
  • 重大產業戰略

4. 持續血糖監測市場：宏觀分析與市場動態

  • 介紹
  • 2023 年至 2033 年全球連續血糖監測市場價值
  • 市場動態
  • 促進因素和限制因素的影響分析
  • 蹺蹺板分析
  • 波特五力模型
  • PESTEL 分析

5. 持續血糖監測市場：2023-2033 年

  • 市場概況
  • 成長與收益分析：2024 年與 2033 年
  • 市場區隔

6. 2023 年至 2033 年持續血糖監測市場（按設備/品牌）

  • 市場概況
  • 成長與收益分析：2024 年與 2033 年
  • 市場區隔
    • Guardian 即時 CGM 系統
    • Dexcom Seven Plus
    • Dexcom G4 白金版
    • 自由式導航器
    • MiniMed Paradigm Revel/Veo 系統
    • 其他

7. 北美持續血糖監測市場：2023-2033 年

8.英國與歐盟持續血糖監測市場：2023-2033 年

9. 亞太地區持續血糖監測市場：2023-2033 年

10. 拉丁美洲持續血糖監測市場：2023-2033 年

11. 中東和非洲持續血糖監測市場：2023-2033 年

第12章 公司簡介

  • Abbott
  • Bayer AG
  • Dexcom Inc.
  • Glysens Incorporated
  • Insulet Corporation
  • Medtronic
  • Nova Biomedical Corporation
  • Senseonics Incorporated
  • Livongo
  • BeatO
  • Jana Care
  • iXensor
  • DiaMonTech AG.
Product Code: 20031-01-25

Continuous Glucose Monitoring (CGM) systems are advanced medical devices that track glucose levels in real-time throughout the day and night. These systems allow individuals with diabetes to see their glucose levels in real-time or monitor them remotely over several days via sensors that are attached to the body. CGM systems provide data that can be used to identify trends and patterns in glucose levels, which can help in tailoring diet, exercise, and insulin requirements. This technology is vital for diabetes management as it provides comprehensive insights into glucose dynamics, unlike traditional blood glucose meters, which only provide a single glucose reading at a time. The continuous glucose monitoring market is projected to expand at a Compound Annual Growth Rate (CAGR) of 9.6%, driven by the increasing prevalence of diabetes globally and the growing demand for real-time glucose monitoring solutions.

Increasing Prevalence of Diabetes

A significant driver for the continuous glucose monitoring (CGM) market is the escalating prevalence of diabetes worldwide. Diabetes has become a global epidemic, with an estimated 537 million adults living with the condition in 2021, a number expected to rise to 643 million by 2030. This surge is largely due to increasing rates of obesity, poor dietary habits, and sedentary lifestyles, especially in urban environments. The growing diabetic population necessitates effective management tools to monitor and control blood glucose levels, thus driving demand for CGM systems. These devices provide real-time insights into glucose trends, enabling patients to manage their condition more effectively and reduce the risk of diabetes-related complications, such as hypoglycemia and hyperglycemia, by facilitating timely interventions.

Integration with Digital Health Platforms

The opportunity for growth in the CGM market is significantly enhanced by the integration of CGM devices with broader digital health platforms. As digital health technology advances, there is a growing trend toward the development of platforms that can integrate data from multiple sources, including CGM systems, to provide a comprehensive overview of a patient's health. This integration allows for more personalized and precise diabetes management strategies, supported by artificial intelligence and machine learning algorithms that can predict glucose fluctuations based on diet, exercise, and other health data. Moreover, the ability to share this data seamlessly with healthcare providers enhances remote monitoring capabilities, making it easier to manage diabetes effectively from a distance, particularly important in the context of the ongoing global push towards telemedicine and remote health management.

Cost and Accessibility Barriers

Despite the benefits of CGM systems, a significant restraint is their cost, which remains prohibitively high for many potential users, especially in low- and middle-income countries. The expense of CGM devices, which includes not only the initial purchase price but also ongoing costs related to sensors, which need regular replacement, can be a barrier to widespread adoption. Additionally, there are accessibility issues, as these systems often require a certain level of technological literacy and access to supportive digital infrastructure, such as smartphones or reliable internet, which may not be available to all users. This economic and technological divide limits the potential market reach of CGM systems and poses challenges to their universal adoption among the global diabetic population.

Data Privacy and Security Concerns

A critical challenge in the CGM market is addressing concerns related to data privacy and security. As CGM systems collect and store vast amounts of personal health information, there is an inherent risk of data breaches, which could expose sensitive health data. The challenge is compounded as these devices become more interconnected with other health systems and platforms, increasing the number of potential vulnerability points. Ensuring robust data protection measures is paramount to maintaining user trust and compliance with stringent regulatory standards regarding health data. This requires continuous investment in cybersecurity measures and regular updates to security protocols, which can be resource-intensive but are essential for safeguarding patient information and ensuring the integrity of remote monitoring health services.

Market Segmentation by Device/Brand

In the continuous glucose monitoring (CGM) market, segmentation by device/brand includes Guardian Real Time CGM System, Dexcom Seven Plus, Dexcom G4 Platinum, FreeStyle Navigator, MiniMed Paradigm Revel/Veo System, and others. Currently, the Dexcom G4 Platinum holds the highest revenue within this segment, attributed to its high accuracy, reliability, and user-friendly interface, which have made it popular among diabetes patients seeking rigorous glucose management. Dexcom's strong brand recognition and established distribution channels contribute significantly to its leading market position. However, the FreeStyle Navigator is projected to experience the highest CAGR. This anticipated growth is driven by its newer technology that offers real-time glucose monitoring without the need for fingerstick calibration, providing greater convenience and reducing the invasiveness of glucose monitoring. As technology advances and patient preferences evolve towards less invasive and more integrated diabetes management solutions, devices like the FreeStyle Navigator are expected to gain significant traction, reflecting broader trends in patient-centered healthcare innovations.

Geographic Trends in the Continuous Glucose Monitoring Market

The continuous glucose monitoring (CGM) market exhibits substantial geographic variations, with North America having generated the highest revenue in 2024. This region's market dominance is attributed to a high prevalence of diabetes, well-established healthcare infrastructure, and widespread adoption of advanced diabetes management technologies. Additionally, favorable reimbursement policies and strong presence of major market players have further supported the extensive use of CGM systems in this region. However, Asia-Pacific is expected to witness the highest CAGR from 2025 to 2033. This growth is driven by increasing awareness of diabetes management, rising healthcare expenditures, and improving healthcare infrastructures in populous countries like China and India. Moreover, the growing middle class in this region is increasingly able to afford advanced healthcare solutions, which contributes to the rapid adoption of innovative technologies such as CGM systems.

Competitive Trends and Key Strategies

In 2024, the competitive landscape of the CGM market was shaped by key players such as Abbott, Bayer AG, Dexcom, Inc., Glysens Incorporated, Insulet Corporation, Medtronic, Nova Biomedical Corporation, Senseonics Incorporated, Livongo, BeatO, Jana Care, iXensor, and DiaMonTech AG. These companies employed a range of strategies to enhance their market positions, including innovation in product offerings, strategic partnerships, and expansions into new geographic markets. For instance, companies like Dexcom and Medtronic focused on technological advancements to improve the accuracy and user-friendliness of their CGM systems, which helped solidify their leadership in the market. Abbott expanded its global footprint by launching its highly popular FreeStyle Libre system in additional international markets, thus broadening its customer base. From 2025 to 2033, these players are expected to continue their focus on innovation, particularly in integrating artificial intelligence to enhance predictive capabilities of CGM devices. Strategic alliances and mergers are anticipated to be prevalent as companies strive to expand their technological capabilities and access new markets. Moreover, as the competition intensifies, companies are likely to invest more in consumer education and direct-to-consumer marketing strategies to increase the adoption rates of their CGM products. The focus on developing less invasive, more accurate, and more integrated CGM solutions will drive the competitive dynamics in this fast-evolving market.

Historical & Forecast Period

This study report represents an analysis of each segment from 2023 to 2033 considering 2024 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2025 to 2033.

The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends & technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. The key data points that enable the estimation of Continuous Glucose Monitoring market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users & consumption volume, price, and value.

Geographical revenues generated by countries considered in the report

Micro and macro environment factors that are currently influencing the Continuous Glucose Monitoring market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.

  • Market Segmentation
    • Device/Brand
  • Guardian Real Time CGM System
  • Dexcom Seven Plus
  • Dexcom G4 Platinum
  • FreeStyle Navigator
  • MiniMed Paradigm Revel/Veo System
  • Others
  • Region Segment (2023-2033; US$ Million)
  • North America
  • U.S.
  • Canada
  • Rest of North America
  • UK and European Union
  • UK
  • Germany
  • Spain
  • Italy
  • France
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East and Africa
  • GCC
  • Africa
  • Rest of Middle East and Africa

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of Continuous Glucose Monitoring market?
  • What are the key investment pockets concerning product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2033.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Continuous Glucose Monitoring market?
  • Which is the largest regional market for Continuous Glucose Monitoring market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Continuous Glucose Monitoring market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Continuous Glucose Monitoring market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Continuous Glucose Monitoring Market
  • 2.2. Global Continuous Glucose Monitoring Market, By , 2024 (US$ Million)
  • 2.3. Global Continuous Glucose Monitoring Market, By Device/Brand, 2024 (US$ Million)
  • 2.4. Global Continuous Glucose Monitoring Market, By Geography, 2024 (US$ Million)
  • 2.5. Attractive Investment Proposition by Geography, 2024

3. Continuous Glucose Monitoring Market: Competitive Analysis

  • 3.1. Market Positioning of Key Continuous Glucose Monitoring Market Vendors
  • 3.2. Strategies Adopted by Continuous Glucose Monitoring Market Vendors
  • 3.3. Key Industry Strategies

4. Continuous Glucose Monitoring Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Continuous Glucose Monitoring Market Value, 2023 - 2033, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis
  • 4.6. Porter's Five Force Model
    • 4.6.1. Supplier Power
    • 4.6.2. Buyer Power
    • 4.6.3. Threat Of Substitutes
    • 4.6.4. Threat Of New Entrants
    • 4.6.5. Competitive Rivalry
  • 4.7. PESTEL Analysis
    • 4.7.1. Political Landscape
    • 4.7.2. Economic Landscape
    • 4.7.3. Technology Landscape
    • 4.7.4. Legal Landscape
    • 4.7.5. Social Landscape

5. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2024 Versus 2033
  • 5.3. Market Segmentation

6. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2024 Versus 2033
  • 6.3. Market Segmentation
    • 6.3.1. Guardian Real Time CGM System
    • 6.3.2. Dexcom Seven Plus
    • 6.3.3. Dexcom G4 Platinum
    • 6.3.4. FreeStyle Navigator
    • 6.3.5. MiniMed Paradigm Revel/Veo System
    • 6.3.6. Others

7. North America Continuous Glucose Monitoring Market, 2023-2033, USD (Million)

  • 7.1. Market Overview
  • 7.2. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
  • 7.3. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)
  • 7.4.Continuous Glucose Monitoring Market: By Region, 2023-2033, USD (Million)
    • 7.4.1.North America
      • 7.4.1.1. U.S.
        • 7.4.1.1.1. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
        • 7.4.1.1.2. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)
      • 7.4.1.2. Canada
        • 7.4.1.2.1. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
        • 7.4.1.2.2. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)
      • 7.4.1.3. Rest of North America
        • 7.4.1.3.1. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
        • 7.4.1.3.2. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)

8. UK and European Union Continuous Glucose Monitoring Market, 2023-2033, USD (Million)

  • 8.1. Market Overview
  • 8.2. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
  • 8.3. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)
  • 8.4.Continuous Glucose Monitoring Market: By Region, 2023-2033, USD (Million)
    • 8.4.1.UK and European Union
      • 8.4.1.1. UK
        • 8.4.1.1.1. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
        • 8.4.1.1.2. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)
      • 8.4.1.2. Germany
        • 8.4.1.2.1. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
        • 8.4.1.2.2. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)
      • 8.4.1.3. Spain
        • 8.4.1.3.1. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
        • 8.4.1.3.2. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)
      • 8.4.1.4. Italy
        • 8.4.1.4.1. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
        • 8.4.1.4.2. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)
      • 8.4.1.5. France
        • 8.4.1.5.1. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
        • 8.4.1.5.2. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)
      • 8.4.1.6. Rest of Europe
        • 8.4.1.6.1. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
        • 8.4.1.6.2. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)

9. Asia Pacific Continuous Glucose Monitoring Market, 2023-2033, USD (Million)

  • 9.1. Market Overview
  • 9.2. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
  • 9.3. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)
  • 9.4.Continuous Glucose Monitoring Market: By Region, 2023-2033, USD (Million)
    • 9.4.1.Asia Pacific
      • 9.4.1.1. China
        • 9.4.1.1.1. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
        • 9.4.1.1.2. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)
      • 9.4.1.2. Japan
        • 9.4.1.2.1. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
        • 9.4.1.2.2. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)
      • 9.4.1.3. India
        • 9.4.1.3.1. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
        • 9.4.1.3.2. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)
      • 9.4.1.4. Australia
        • 9.4.1.4.1. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
        • 9.4.1.4.2. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)
      • 9.4.1.5. South Korea
        • 9.4.1.5.1. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
        • 9.4.1.5.2. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)
      • 9.4.1.6. Rest of Asia Pacific
        • 9.4.1.6.1. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
        • 9.4.1.6.2. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)

10. Latin America Continuous Glucose Monitoring Market, 2023-2033, USD (Million)

  • 10.1. Market Overview
  • 10.2. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
  • 10.3. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)
  • 10.4.Continuous Glucose Monitoring Market: By Region, 2023-2033, USD (Million)
    • 10.4.1.Latin America
      • 10.4.1.1. Brazil
        • 10.4.1.1.1. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
        • 10.4.1.1.2. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)
      • 10.4.1.2. Mexico
        • 10.4.1.2.1. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
        • 10.4.1.2.2. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)
      • 10.4.1.3. Rest of Latin America
        • 10.4.1.3.1. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
        • 10.4.1.3.2. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)

11. Middle East and Africa Continuous Glucose Monitoring Market, 2023-2033, USD (Million)

  • 11.1. Market Overview
  • 11.2. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
  • 11.3. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)
  • 11.4.Continuous Glucose Monitoring Market: By Region, 2023-2033, USD (Million)
    • 11.4.1.Middle East and Africa
      • 11.4.1.1. GCC
        • 11.4.1.1.1. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
        • 11.4.1.1.2. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)
      • 11.4.1.2. Africa
        • 11.4.1.2.1. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
        • 11.4.1.2.2. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)
      • 11.4.1.3. Rest of Middle East and Africa
        • 11.4.1.3.1. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
        • 11.4.1.3.2. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)

12. Company Profile

  • 12.1. Abbott
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Portfolio
    • 12.1.4. Strategic Initiatives
  • 12.2. Bayer AG
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Portfolio
    • 12.2.4. Strategic Initiatives
  • 12.3. Dexcom, Inc.
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Portfolio
    • 12.3.4. Strategic Initiatives
  • 12.4. Glysens Incorporated
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Portfolio
    • 12.4.4. Strategic Initiatives
  • 12.5. Insulet Corporation
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Portfolio
    • 12.5.4. Strategic Initiatives
  • 12.6. Medtronic
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Portfolio
    • 12.6.4. Strategic Initiatives
  • 12.7. Nova Biomedical Corporation
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Portfolio
    • 12.7.4. Strategic Initiatives
  • 12.8. Senseonics Incorporated
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Portfolio
    • 12.8.4. Strategic Initiatives
  • 12.9. Livongo
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Portfolio
    • 12.9.4. Strategic Initiatives
  • 12.10. BeatO
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Portfolio
    • 12.10.4. Strategic Initiatives
  • 12.11. Jana Care
    • 12.11.1. Company Overview
    • 12.11.2. Financial Performance
    • 12.11.3. Product Portfolio
    • 12.11.4. Strategic Initiatives
  • 12.12. iXensor
    • 12.12.1. Company Overview
    • 12.12.2. Financial Performance
    • 12.12.3. Product Portfolio
    • 12.12.4. Strategic Initiatives
  • 12.13. DiaMonTech AG.
    • 12.13.1. Company Overview
    • 12.13.2. Financial Performance
    • 12.13.3. Product Portfolio
    • 12.13.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
  • TABLE 2 Global Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
  • TABLE 3 North America Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
  • TABLE 4 North America Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
  • TABLE 5 U.S. Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
  • TABLE 6 U.S. Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
  • TABLE 7 Canada Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
  • TABLE 8 Canada Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
  • TABLE 9 Rest of North America Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
  • TABLE 10 Rest of North America Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
  • TABLE 11 UK and European Union Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
  • TABLE 12 UK and European Union Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
  • TABLE 13 UK Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
  • TABLE 14 UK Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
  • TABLE 15 Germany Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
  • TABLE 16 Germany Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
  • TABLE 17 Spain Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
  • TABLE 18 Spain Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
  • TABLE 19 Italy Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
  • TABLE 20 Italy Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
  • TABLE 21 France Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
  • TABLE 22 France Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
  • TABLE 23 Rest of Europe Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
  • TABLE 24 Rest of Europe Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
  • TABLE 25 Asia Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
  • TABLE 26 Asia Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
  • TABLE 27 China Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
  • TABLE 28 China Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
  • TABLE 29 Japan Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
  • TABLE 30 Japan Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
  • TABLE 31 India Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
  • TABLE 32 India Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
  • TABLE 33 Australia Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
  • TABLE 34 Australia Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
  • TABLE 35 South Korea Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
  • TABLE 36 South Korea Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
  • TABLE 37 Latin America Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
  • TABLE 38 Latin America Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
  • TABLE 39 Brazil Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
  • TABLE 40 Brazil Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
  • TABLE 41 Mexico Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
  • TABLE 42 Mexico Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
  • TABLE 43 Rest of Latin America Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
  • TABLE 44 Rest of Latin America Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
  • TABLE 45 Middle East and Africa Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
  • TABLE 46 Middle East and Africa Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
  • TABLE 47 GCC Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
  • TABLE 48 GCC Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
  • TABLE 49 Africa Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
  • TABLE 50 Africa Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
  • TABLE 51 Rest of Middle East and Africa Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
  • TABLE 52 Rest of Middle East and Africa Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)

List of Figures

  • FIG. 1 Global Continuous Glucose Monitoring Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Continuous Glucose Monitoring Market: Quality Assurance
  • FIG. 5 Global Continuous Glucose Monitoring Market, By , 2024
  • FIG. 6 Global Continuous Glucose Monitoring Market, By Device/Brand, 2024
  • FIG. 7 Global Continuous Glucose Monitoring Market, By Geography, 2024
  • FIG. 8 Market Geographical Opportunity Matrix - Global Continuous Glucose Monitoring Market, 2024
  • FIG. 9Market Positioning of Key Continuous Glucose Monitoring Market Players, 2024
  • FIG. 10 Global Continuous Glucose Monitoring Market, By , 2024 Vs 2033, %
  • FIG. 11 Global Continuous Glucose Monitoring Market, By Device/Brand, 2024 Vs 2033, %